These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15261939)

  • 1. Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?
    Borer JS
    J Am Coll Cardiol; 2004 Jul; 44(2):406-8. PubMed ID: 15261939
    [No Abstract]   [Full Text] [Related]  

  • 2. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.
    Maron BJ; Seidman CE; Ackerman MJ; Towbin JA; Maron MS; Ommen SR; Nishimura RA; Gersh BJ
    Circ Cardiovasc Genet; 2009 Feb; 2(1):81-5; discussion 86. PubMed ID: 20031569
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese-type apical hypertrophic cardiomyopathy.
    Nussinovitch U; Ezra D; Nussinovitch N; Shoenfeld Y
    Isr Med Assoc J; 2009 Nov; 11(11):705. PubMed ID: 20108564
    [No Abstract]   [Full Text] [Related]  

  • 6. A strong negative correlation was found between heart rate variability and left ventricular mass in patients with cardiac hypertrophy.
    Faludi R; Toth L
    Am Heart J; 2006 Jul; 152(1):e13; author reply e15. PubMed ID: 16824819
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial dysfunction in hypertrophic cardiomyopathy.
    Ashrafian H; Watkins H
    Circulation; 2001 Dec; 104(25):E165. PubMed ID: 11748129
    [No Abstract]   [Full Text] [Related]  

  • 8. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recomendations on management of left ventricular hypertrophy in athletes. The Working Group of Sports Cardiology of the French Society of Cardiology].
    Brion R;
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):195-206. PubMed ID: 17536423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
    Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic anterior motion (SAM) of the posterior mitral leaflet: left ventricular outflow tract obstruction in a patient without left ventricular hypertrophy.
    Doi T; Ayukawa H; Hoshiyama Y; Hatakeyama Y; Sasaki Y; Inenaga K; Hwang MW; Takeoka R; Iwase T; Kawai C
    Int J Cardiol; 2006 May; 109(2):271-2. PubMed ID: 15939492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prediction rule for left ventricular dilatation post-MI?
    St John Sutton M; Scott CH
    Eur Heart J; 2002 Apr; 23(7):509-11. PubMed ID: 11922636
    [No Abstract]   [Full Text] [Related]  

  • 14. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
    Maurizi N; Michels M; Rowin EJ; Semsarian C; Girolami F; Tomberli B; Cecchi F; Maron MS; Olivotto I; Maron BJ
    Circulation; 2019 Feb; 139(6):830-833. PubMed ID: 30715937
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of left ventricular remodeling in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    Am J Cardiol; 1998 Jun; 81(11):1339-44. PubMed ID: 9631972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphologic aspects of the left ventricular remodeling in hypertensive cardiomyopathy].
    Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1995 Dec; 65(6):523-7. PubMed ID: 8731308
    [No Abstract]   [Full Text] [Related]  

  • 18. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Late ventricular potentials and left ventricular performance in patients with hypertrophic cardiomyopathy].
    Ianovskiĭ GV; Ianovskiĭ AD; Solov'ian AN; Terzov AI
    Kardiologiia; 1992 May; 32(5):11-2. PubMed ID: 1405248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apical hypertrophic cardiomyopathy in Japan and the United States in brothers but not identical twins.
    Abinader EG
    Am J Cardiol; 2004 Oct; 94(7):981. PubMed ID: 15464699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.